default author photo

Brett L. Hurst

Utah State University - Institute for Antiviral Research

SCHOLARLY PAPERS

3

DOWNLOADS

81

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

BDAA, a yellow fever virus NS4B inhibitor, is effective during therapeutic treatment in a hamster model of yellow fever

Number of pages: 15 Posted: 27 Feb 2026
Abbie E. Weight, Arnaud J. Van Wettere, Shawn M. Zimmerman, Yanming Du, Fuxuan Wang, Mirella L. Meyer-Ficca, Brett L. Hurst, Jinhong Chang and Justin Julander
affiliation not provided to SSRN, Utah State University, Michigan State University, affiliation not provided to SSRN, affiliation not provided to SSRN, Utah State University - Department of Animal, Dairy, and Veterinary Sciences, Utah State University - Institute for Antiviral Research, affiliation not provided to SSRN and Utah State University
Downloads 37 (1,318,317)

Abstract:

Loading...

Yellow fever virus, Antiviral, animal model, NS4B inhibitor, flavivirus

2.

Tempol Inhibits SARS-CoV-2 Replication and Development of Lung Disease in the Syrian Hamster Model

Number of pages: 28 Posted: 30 Jun 2022
Nunziata Maio, Sara Cherry, David C. Schultz, Brett L. Hurst, W. Marston Linehan and Tracey A. Rouault
National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development - Molecular Medicine Branch, University of Pennsylvania - Department of Pathology and Laboratory Medicine, University of Pennsylvania - Department of Biochemistry and Biophysics, Utah State University - Institute for Antiviral Research, National Institutes of Health, National Cancer Institute - Urologic Oncology Branch and National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development - Molecular Medicine Branch
Downloads 33 (1,277,121)

Abstract:

Loading...

SARS-CoV-2, iron-sulfur clusters, TEMPOL, SARS-CoV, MERS-CoV

3.

The use of Mixed-size Nanoparticulate Vaccine Design as a Strategy to Boost Immunogenicity, Efficacy, and Dose Sparing Protection Against Pandemic Influenza

Number of pages: 47 Posted: 23 Jun 2026
Tülin Morçöl, Brett L. Hurst and E. Bart Tarbet
affiliation not provided to SSRN, Utah State University - Institute for Antiviral Research and Utah State University
Downloads 11

Abstract:

Loading...

Calcium phosphate nanoparticles, nanoparticle adjuvant, A/H1N1pdm09, pandemic influenza, dose-sparing, whole inactivated influenza vaccines